FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18042511000001108: Pramipexole 2.62mg modified-release tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62170101000001112 Pramipexole 2.62mg modified-release tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62170201000001117 Pramipexole 2.62mg modified-release tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

16 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pramipexole 2.62mg modified-release tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet Has VMP Pramipexole 2.62mg modified-release tablets true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets 30 tablet Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pramipexole 2.62mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (DE Pharmaceuticals) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Oprymea 2.62mg modified-release tablets (CST Pharma Ltd) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Sifrol 2.62mg modified-release tablets (Ethigen Ltd) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (Medihealth (Northern) Ltd) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Boehringer Ingelheim Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Lexon (UK) Ltd) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Oprymea 2.62mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pipexus 2.62mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (Zentiva Pharma UK Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Pramipexole 2.62mg modified-release tablets (Viatris UK Healthcare Ltd) 30 tablet 3 x 10 tablets Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Mirapexin 2.62mg modified-release tablets (Originalis B.V.) 30 tablet Is a True Pramipexole 2.62mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start